Search Results

February 06, 2019  

The Grapevine

Pharmaceutical-stock analysts David Kim and Alex Virgilio left Partner Fund Management in late January. Their plans are unknown. Virgilio arrived at Chris James’ San Francisco firm in 2007 from biotechnology company Amgen. Kim’s background is unknown.

This article is free to subscribers of Hedge Fund Alert. If you are a subscriber, please sign in.

If you are not a subscriber, please complete the form below to purchase the article for $19.95.
First Name *
Last Name *
E-mail *
Card Number *
Expiration *
Card Code *
Address *
City *
State/Province *
Zip/Postal Code *

Purchase Article